Natco Pharma (BOM:524816) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524816 Natco Pharma Ltd BOM:524816
84 GF Score
Price ₹950.55
GF Value ₹928.77
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Natco Pharma FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524816
84GF Score
Natco Pharma Ltd BOM:524816
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Natco Pharma (BOM:524816) Overvalued in 2026?

Based on GuruFocus' analysis, Natco Pharma stock appears to be overvalued. The current stock price of ₹950.55 is trading 2.3% above its estimated GF Value™ of ₹928.77. GuruFocus considers Natco Pharma to be Fairly Valued.

Key valuation signals for BOM:524816:

  • FFO:
  • GF Value™: ₹928.77 vs. price of ₹950.55 (2.3% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the BOM:524816 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Natco Pharma Business Description

Other Exchanges NATCOPHARM:India
Address Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
84GF Score

Get the complete analysis for BOM:524816

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹950.55
Price
₹928.77
GF Value